Development of a Platform for the Clinical Implementation of Precision Oncology in the Central-Southern Regions of Italy (COESIT)

NCT06894823 · tracked via the Priya Life Science Italy tracker

Sponsor

National Cancer Institute, Naples

Phase

Observational

Started

2024-12-10

Last updated

2025-03-25

Condition(s) studied

Neoplasm

Investigational drug(s) / intervention(s)

Creation of a laboratory networkMapping of genomic alterationsCreation of a bioinformatics network among the participating institutions.Development of a platform for the collection of clinicopathological and genetic-molecular data.Identification of prognostic and predictive factors for the implementation of precision oncology strategies based on genomic profiling.

Creation of a laboratory network: Creation of a laboratory network in Central-Southern Italy capable of performing complex genomic analyses.

Mapping of genomic alterations: Mapping of genomic alterations aimed at precision medicine and personalized diagnostic and therapeutic approaches.

Creation of a bioinformatics network among the participating institutions.: Creation of a bioinformatics network among the participating institutions.

Development of a platform for the collection of clinicopathological and genetic-molecular data.: Development of a platform for the collection of clinicopathological and genetic-molecular data.

Identification of prognostic and predictive factors for the implementation of precision oncology strategies based on genomic profiling.: Identification of prognostic and predictive factors for the implementation of precision oncology strategies based on genomic profiling.

Study summary

COESIT aims to establish a network of reference laboratories in the central-southern regions of Italy for the genetic and molecular characterization of tumors, with the goal of implementing precision and personalized oncology in clinical practice.

Eligibility

Sex

ALL

Min age

—

Max age

—

Healthy volunteers

Inclusion Criteria: * Cancer patients * Patients from the central-southern regions Exclusion Criteria: \-

Primary outcome measure(s)

Improvement of diagnostic precision in oncology based on advanced molecular profiling tools. — 4 years

Trial sites (1)

Facility	City	Region	Status
Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pascale	Naples	Italy	Recruiting

More National Cancer Institute, Naples trials in Italy

Molecular-Based Selection of Patients with Head and Neck Squamous Cell Carcinoma: Biomarker Analysis Recruiting

Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt) Recruiting

PRO for Fighting FT in Ovarian Cancer Recruiting

Real-world Efficacy and Safety of Neoadjuvant Dostarlimab in Patients With dMMR/MSI-H Locally Advanced Rectal Cancer Recruiting

STREAM-2: Second-line Treatment With REgorafenib in Advanced RAS-Mutant Colorectal Cancer Recruiting

Other trials for the same condition

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study Recruiting

Using Artificial Intelligence to Guide Fluid Therapy During Major Cancer Surgery: A Randomized Controlled Trial Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06894823 on ClinicalTrials.gov ↗ ← All trials in Italy